Acute Ischemic Stroke in the Coronavirus Disease 2019 Era: An Analysis From Get With the Guidelines-Stroke

This presentation evaluates acute ischemic stroke (AIS) care during the Coronavirus Disease 2019 (COVID-19) pandemic using the Get With The Guidelines Stroke (GWTG-Stroke) registry. While AIS stroke presentations have declined, stroke care for the general population remains robust among GWTG-stroke hospitals in the US during COVID-19. Patients with concomitant AIS and COVID-19, however, were found to have more severe strokes, delays in diagnosis and treatment, and worse outcomes during the pandemic.

{{assetTitle}}

Authors {{assetAuthors}}

Published date{{formattedPublishDate}}

{{assetDescription}}

Welcome to Medically

The Roche Science Hub

This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.

I am a healthcare professional

Not a healthcare professional? Browse:

Roche's patients website Roche.com

This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.

You are Leaving Medically

By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.

Leave Site Stay on Medically